Poliovirus has been identified in London wastewater for the second time this year, days after ministers moved to withdraw UK support for global eradication efforts. Routine testing picked up the latest signal in a sample collected on 2 March, subsequently listed in the Global Polio Eradication Initiative’s weekly reporting. Public-health specialists warned the finding underscores how quickly immunity gaps can convert international viral traffic into local exposure, even in countries that have long since interrupted endemic transmission.
Wastewater signal and what it shows
UK health authorities conduct weekly environmental surveillance across sewage treatment works in England, a system designed to flag silent circulation before clinical cases appear and mandated as part of the country’s wider infectious-disease surveillance duties under the Health Protection (Notification) Regulations. In London, the current detection is the 10th wastewater finding since 2024 and involves vaccine-derived poliovirus type 2, the form most often linked to outbreaks in undervaccinated settings.
- Detection timeline: sample collected on 2 March; listed in the latest weekly global reporting cycle.
- Classification: circulating vaccine-derived poliovirus (cVDPV2) signal in wastewater, pending further sequencing and risk assessment.
- Geography: London Beckton sewage treatment works, serving a large and highly mobile urban catchment.
- Surveillance modality: weekly environmental sampling led by UKHSA in partnership with MHRA; part of routine national surveillance, not triggered by suspected cases.
- Epidemiological interpretation: a single positive sample indicates recent shedding in the catchment but does not equate to a confirmed clinical case or sustained community transmission.
“The finding, once again, of poliovirus in sewage samples in London indicates there is an ongoing risk that the virus is transmitting in the city. This is a very worrying situation in communities with low vaccination rates, an ongoing danger to health in parts of London, as polio infection can be devastating,” said Prof Sir Andrew Pollard, the director of the Oxford Vaccine Group at the University of Oxford.
What a positive sample does-and does not-mean
Dr Kathleen O’Reilly, an epidemiologist at the London School of Hygiene and Tropical Medicine, cautioned that it is “too soon to tell” whether the signal reflects a traveller returning from a country where polio is present or where the oral vaccine is in use, or whether it suggests early local spread. She added that it was important to emphasise that a positive sewage sample “doesn’t correspond to a paralytic case”, and said UKHSA would be working closely with hospitals and GP practices to be on extra alert for any neurological symptoms consistent with polio.
- Key caveat: wastewater findings track faecal shedding, not cases; most poliovirus infections are asymptomatic or mild, meaning paralytic disease is the tip of a much larger transmission iceberg.
- Immediate operational response: enhanced clinical vigilance, targeted community engagement within the catchment, and additional sampling to determine whether the signal recurs.
- Regional pattern: similar wastewater reports have increased in parts of Europe, including Germany, reflecting wider mobility, immunity gaps and the continued use of oral polio vaccines in some countries.
How the UK’s surveillance net functions
Environmental monitoring involves collecting weekly samples from sewage plants across England, concentrating and testing them for poliovirus using validated laboratory methods overseen by UKHSA and MHRA. The approach complements clinical notification and enables earlier risk assessment than waiting for paralytic cases. A detailed overview of the sampling framework is available through the UK’s environmental surveillance programme for polio, which sets out site selection, testing cadence and reporting pathways via official guidance issued by the Department of Health and Social Care.
| System capacity element | Current status and purpose |
|---|---|
| Environmental sampling | Weekly at designated sewage treatment works to detect silent circulation and inform rapid risk assessments before patients present with paralysis. |
| Regulatory coordination | UKHSA-MHRA collaboration to assure assay quality, data integrity and signal verification, including confirmatory testing where needed. |
| Clinical surveillance | Alerts to hospitals and GP practices in affected areas to heighten case finding for acute flaccid paralysis and ensure rapid notification of suspected polio under national notifiable-disease rules. |
| Public communication | Targeted messaging in communities with lower vaccine uptake to close immunity gaps without causing undue alarm, alongside clear advice on how to check and complete vaccination schedules. |
Immunisation coverage and urban vulnerability
Mass vaccination has eliminated polio from most of the world, but small coverage dips can reopen transmission channels in large cities with high population churn and persistent health inequalities. London, where some boroughs fall well below national averages for childhood immunisations, remains a particular focus for UKHSA and local public-health teams.
- Coverage trend in the UK: completion of all three infant polio doses declined from 95% (2012-2015) to 92% in 2022-23, with steeper falls in some urban and deprived communities.
- Urban risk factors: concentrated pockets of under-immunisation, international travel, temporary migration and household crowding can amplify spread from a single imported or vaccine-derived virus.
- Clinical severity: paralysis arises when the virus damages nerves in the spine or brainstem and can be life-threatening if respiratory muscles are affected; survivors may be left with permanent disability.
Funding retreat collides with eradication endgame
Polio eradication remains within reach but highly sensitive to funding shocks and political decisions in major donor countries. The UK has historically been the second-largest government donor to the eradication partnership after the United States, aligning its contributions with broader commitments on global health security and pandemic preparedness.
On 19 March 2026, ministers set out plans to eliminate UK support for the Global Polio Eradication Initiative as part of more than £6bn in aid reductions, a move that lands just as the partnership’s 2026 budget is already 30% below plan, forcing cuts to surveillance and rapid response in some of the highest-risk settings. Public-health experts warn that reductions in core polio funding can also weaken laboratories and field teams that underpin wider outbreak detection, from measles to emerging pathogens.
Adrian Lovett, the UK executive director at One, an anti-poverty campaign group, said: “Covid showed us that viruses do not respect borders. No matter how wealthy a country may be, our defence against public health emergencies depends on our neighbours and we are only ever as strong as our weakest link.
“That is why the UK government’s decision to slash international assistance is so short-sighted and self-defeating. Not only do we have a moral responsibility to the world’s most disadvantaged people, but it also puts the UK public in greater danger.”
| Date | Policy measure | Anticipated public-health impact |
|---|---|---|
| 2 March 2026 | London wastewater sample positive for vaccine-derived poliovirus type 2 | Triggers enhanced vigilance and targeted surveillance; no paralytic cases required to act. |
| 19 March 2026 | Announcement to eliminate UK funding for the global eradication partnership | Reduced outbreak response and surveillance capacity in low-resource settings; higher importation risk to the UK and Europe over time. |
Expert risk framing from UKHSA
Dr Vanessa Saliba, a consultant epidemiologist at UKHSA, said: “UKHSA works closely with the MHRA [Medicines and Healthcare products Regulatory Agency] to conduct routine polio environmental surveillance as part of our commitment to global polio eradication. In the UK this year, there have been two unrelated detections of vaccine-derived polio virus type 2 in sewage collected from London Beckton sewage treatment works. One-off detections like this are not unusual. The findings are consistent with importations and there is no evidence of local transmission.
“While the risk to the general public is very low, parents should ensure their children are fully up to date with their polio vaccinations. Check your child’s red book and contact your GP practice to catch up on any missing vaccinations.”
- Current risk level: assessed by UKHSA as very low for the general public; targeted attention warranted where vaccination coverage lags, especially in specific London boroughs.
- Operational stance: continue routine surveillance, maintain healthcare alerting, and address local immunity gaps through catch-up campaigns and primary-care outreach.
Global picture: endgame risks and the oral vaccine paradox
Wild poliovirus persists in limited areas of Afghanistan and Pakistan. The wastewater signal in London involves a vaccine-derived strain, which can emerge when the weakened virus from the oral polio vaccine is shed and, in under-immunised communities, mutates toward neurovirulence. This so‑called “oral vaccine paradox” means that tools used to crush outbreaks can themselves seed new ones if basic immunisation coverage is not maintained.
Worldwide, there were 225 recorded cases of cVDPV in 2025, underscoring the need to finish the transition from short-term outbreak response to sustainable prevention, as tracked by the eradication partnership’s global cVDPV count. The London detections highlight how decisions taken in Westminster on aid, surveillance and vaccine policy reverberate through this global endgame.
- Drivers of residual risk: immunity gaps, programmatic interruptions, conflict and population displacement can all create conditions for vaccine-derived strains to circulate.
- Mitigation levers: sustained financing for surveillance and rapid response; resilient routine immunisation; cross-border coordination between health authorities and multilateral partners.
- Communications landscape: rising anti-vaccine sentiment in some countries has raised concern about renewed vulnerability, prompting health agencies to balance reassurance with clear calls to complete vaccination schedules.
